Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans

Degree of liver fibrosis largely determines treatment urgency for hepatitis C virus (HCV). This retrospective study examined fibrosis stages and predictive factors in African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV coinfection. Nearly 50% of patients had early-sta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2013-05, Vol.56 (9), p.1280-1283
Hauptverfasser: Silver, D., Karnik, G., Osinusi, A., Silk, R., Stabinski, L., Doonquah, L., Henn, S., Teferi, G., Masur, H., Kottilil, S., Fishbein, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1283
container_issue 9
container_start_page 1280
container_title Clinical infectious diseases
container_volume 56
creator Silver, D.
Karnik, G.
Osinusi, A.
Silk, R.
Stabinski, L.
Doonquah, L.
Henn, S.
Teferi, G.
Masur, H.
Kottilil, S.
Fishbein, D.
description Degree of liver fibrosis largely determines treatment urgency for hepatitis C virus (HCV). This retrospective study examined fibrosis stages and predictive factors in African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV coinfection. Nearly 50% of patients had early-stage fibrosis in the study, despite the long duration of infection in many patients. HIV was associated with the early fibrosis group. These results indicate that a large proportion of patients with HCV infection, including those with HIV, could possibly await more-effective and better-tolerated treatment.
doi_str_mv 10.1093/cid/cit037
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3657492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>23483469</jstor_id><sourcerecordid>23483469</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-86d65004f8aff826380f5cfb281f540831d783537058709bf0da553656c590af3</originalsourceid><addsrcrecordid>eNpdkUtLAzEURoMoWh8b98qACCKMJpPJTGYjlNraQsGNug1pJtGUaaLJtOC_9_ahVhchF-7h8CUfQqcE3xBc0VtlazgtpuUO6hBGy7RgFdmFGTOe5pzyA3QY4xRjQjhm--ggo7TkGacddN83Rqs28SYZjl4S75KxXeiQDOwk-Ghj0p1595oMey_pyC1JXSddE6ySDlZ6NcRjtGdkE_XJ5j5Cz4P-U2-Yjh8fRr3uOFU5423Ki7pgGOeGS2N4VlCODVNmknFiWI45JXXJKeSH2CWuJgbXkjFasEKxCktDj9Dd2vs-n8x0rbRrg2zEe7AzGT6Fl1b83Tj7Jl79QoCjzKsMBFcbQfAfcx1bMbNR6aaRTvt5FIRmOa0wYQTQi3_o1M-Dg-etKPBlK-p6TSn4rRi0-QlDsFiWI6AcsS4H4PPt-D_odxsAXG4AGZVsTJBO2fjLlRkFrADubM1NY-vDlge6zouKfgGdSp7y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1324574251</pqid></control><display><type>article</type><title>Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Silver, D. ; Karnik, G. ; Osinusi, A. ; Silk, R. ; Stabinski, L. ; Doonquah, L. ; Henn, S. ; Teferi, G. ; Masur, H. ; Kottilil, S. ; Fishbein, D.</creator><creatorcontrib>Silver, D. ; Karnik, G. ; Osinusi, A. ; Silk, R. ; Stabinski, L. ; Doonquah, L. ; Henn, S. ; Teferi, G. ; Masur, H. ; Kottilil, S. ; Fishbein, D.</creatorcontrib><description>Degree of liver fibrosis largely determines treatment urgency for hepatitis C virus (HCV). This retrospective study examined fibrosis stages and predictive factors in African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV coinfection. Nearly 50% of patients had early-stage fibrosis in the study, despite the long duration of infection in many patients. HIV was associated with the early fibrosis group. These results indicate that a large proportion of patients with HCV infection, including those with HIV, could possibly await more-effective and better-tolerated treatment.</description><identifier>ISSN: 1058-4838</identifier><identifier>ISSN: 1537-6591</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/cit037</identifier><identifier>PMID: 23378283</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adolescent ; Adult ; African Americans ; Aged ; Alcohols ; Biological and medical sciences ; Biopsies ; Black or African American ; BRIEF REPORT ; Coinfection ; Coinfection - complications ; Female ; Fibrosis ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepacivirus ; Hepatitis ; Hepatitis C, Chronic - complications ; HIV ; HIV Infections - complications ; Human immunodeficiency virus ; Human viral diseases ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infections ; Infectious diseases ; Liver ; Liver Cirrhosis - epidemiology ; Liver Cirrhosis - pathology ; Liver diseases ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Medical treatment ; Middle Aged ; Other diseases. Semiology ; Retrospective Studies ; RNA ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral infections ; Young Adult</subject><ispartof>Clinical infectious diseases, 2013-05, Vol.56 (9), p.1280-1283</ispartof><rights>Copyright © 2013 Oxford University Press on behalf of the Infectious Diseases Society of America</rights><rights>2014 INIST-CNRS</rights><rights>Copyright Oxford University Press, UK May 1, 2013</rights><rights>Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2013. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-86d65004f8aff826380f5cfb281f540831d783537058709bf0da553656c590af3</citedby><cites>FETCH-LOGICAL-c458t-86d65004f8aff826380f5cfb281f540831d783537058709bf0da553656c590af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/23483469$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/23483469$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,776,780,799,881,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27232836$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23378283$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silver, D.</creatorcontrib><creatorcontrib>Karnik, G.</creatorcontrib><creatorcontrib>Osinusi, A.</creatorcontrib><creatorcontrib>Silk, R.</creatorcontrib><creatorcontrib>Stabinski, L.</creatorcontrib><creatorcontrib>Doonquah, L.</creatorcontrib><creatorcontrib>Henn, S.</creatorcontrib><creatorcontrib>Teferi, G.</creatorcontrib><creatorcontrib>Masur, H.</creatorcontrib><creatorcontrib>Kottilil, S.</creatorcontrib><creatorcontrib>Fishbein, D.</creatorcontrib><title>Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Degree of liver fibrosis largely determines treatment urgency for hepatitis C virus (HCV). This retrospective study examined fibrosis stages and predictive factors in African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV coinfection. Nearly 50% of patients had early-stage fibrosis in the study, despite the long duration of infection in many patients. HIV was associated with the early fibrosis group. These results indicate that a large proportion of patients with HCV infection, including those with HIV, could possibly await more-effective and better-tolerated treatment.</description><subject>Adolescent</subject><subject>Adult</subject><subject>African Americans</subject><subject>Aged</subject><subject>Alcohols</subject><subject>Biological and medical sciences</subject><subject>Biopsies</subject><subject>Black or African American</subject><subject>BRIEF REPORT</subject><subject>Coinfection</subject><subject>Coinfection - complications</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepacivirus</subject><subject>Hepatitis</subject><subject>Hepatitis C, Chronic - complications</subject><subject>HIV</subject><subject>HIV Infections - complications</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Liver</subject><subject>Liver Cirrhosis - epidemiology</subject><subject>Liver Cirrhosis - pathology</subject><subject>Liver diseases</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>Retrospective Studies</subject><subject>RNA</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral infections</subject><subject>Young Adult</subject><issn>1058-4838</issn><issn>1537-6591</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLAzEURoMoWh8b98qACCKMJpPJTGYjlNraQsGNug1pJtGUaaLJtOC_9_ahVhchF-7h8CUfQqcE3xBc0VtlazgtpuUO6hBGy7RgFdmFGTOe5pzyA3QY4xRjQjhm--ggo7TkGacddN83Rqs28SYZjl4S75KxXeiQDOwk-Ghj0p1595oMey_pyC1JXSddE6ySDlZ6NcRjtGdkE_XJ5j5Cz4P-U2-Yjh8fRr3uOFU5423Ki7pgGOeGS2N4VlCODVNmknFiWI45JXXJKeSH2CWuJgbXkjFasEKxCktDj9Dd2vs-n8x0rbRrg2zEe7AzGT6Fl1b83Tj7Jl79QoCjzKsMBFcbQfAfcx1bMbNR6aaRTvt5FIRmOa0wYQTQi3_o1M-Dg-etKPBlK-p6TSn4rRi0-QlDsFiWI6AcsS4H4PPt-D_odxsAXG4AGZVsTJBO2fjLlRkFrADubM1NY-vDlge6zouKfgGdSp7y</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Silver, D.</creator><creator>Karnik, G.</creator><creator>Osinusi, A.</creator><creator>Silk, R.</creator><creator>Stabinski, L.</creator><creator>Doonquah, L.</creator><creator>Henn, S.</creator><creator>Teferi, G.</creator><creator>Masur, H.</creator><creator>Kottilil, S.</creator><creator>Fishbein, D.</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130501</creationdate><title>Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans</title><author>Silver, D. ; Karnik, G. ; Osinusi, A. ; Silk, R. ; Stabinski, L. ; Doonquah, L. ; Henn, S. ; Teferi, G. ; Masur, H. ; Kottilil, S. ; Fishbein, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-86d65004f8aff826380f5cfb281f540831d783537058709bf0da553656c590af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>African Americans</topic><topic>Aged</topic><topic>Alcohols</topic><topic>Biological and medical sciences</topic><topic>Biopsies</topic><topic>Black or African American</topic><topic>BRIEF REPORT</topic><topic>Coinfection</topic><topic>Coinfection - complications</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepacivirus</topic><topic>Hepatitis</topic><topic>Hepatitis C, Chronic - complications</topic><topic>HIV</topic><topic>HIV Infections - complications</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Liver</topic><topic>Liver Cirrhosis - epidemiology</topic><topic>Liver Cirrhosis - pathology</topic><topic>Liver diseases</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>Retrospective Studies</topic><topic>RNA</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral infections</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silver, D.</creatorcontrib><creatorcontrib>Karnik, G.</creatorcontrib><creatorcontrib>Osinusi, A.</creatorcontrib><creatorcontrib>Silk, R.</creatorcontrib><creatorcontrib>Stabinski, L.</creatorcontrib><creatorcontrib>Doonquah, L.</creatorcontrib><creatorcontrib>Henn, S.</creatorcontrib><creatorcontrib>Teferi, G.</creatorcontrib><creatorcontrib>Masur, H.</creatorcontrib><creatorcontrib>Kottilil, S.</creatorcontrib><creatorcontrib>Fishbein, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silver, D.</au><au>Karnik, G.</au><au>Osinusi, A.</au><au>Silk, R.</au><au>Stabinski, L.</au><au>Doonquah, L.</au><au>Henn, S.</au><au>Teferi, G.</au><au>Masur, H.</au><au>Kottilil, S.</au><au>Fishbein, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>56</volume><issue>9</issue><spage>1280</spage><epage>1283</epage><pages>1280-1283</pages><issn>1058-4838</issn><issn>1537-6591</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Degree of liver fibrosis largely determines treatment urgency for hepatitis C virus (HCV). This retrospective study examined fibrosis stages and predictive factors in African Americans with HCV monoinfection and human immunodeficiency virus (HIV)/HCV coinfection. Nearly 50% of patients had early-stage fibrosis in the study, despite the long duration of infection in many patients. HIV was associated with the early fibrosis group. These results indicate that a large proportion of patients with HCV infection, including those with HIV, could possibly await more-effective and better-tolerated treatment.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>23378283</pmid><doi>10.1093/cid/cit037</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2013-05, Vol.56 (9), p.1280-1283
issn 1058-4838
1537-6591
1537-6591
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3657492
source Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adolescent
Adult
African Americans
Aged
Alcohols
Biological and medical sciences
Biopsies
Black or African American
BRIEF REPORT
Coinfection
Coinfection - complications
Female
Fibrosis
Gastroenterology. Liver. Pancreas. Abdomen
Hepacivirus
Hepatitis
Hepatitis C, Chronic - complications
HIV
HIV Infections - complications
Human immunodeficiency virus
Human viral diseases
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infections
Infectious diseases
Liver
Liver Cirrhosis - epidemiology
Liver Cirrhosis - pathology
Liver diseases
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Medical treatment
Middle Aged
Other diseases. Semiology
Retrospective Studies
RNA
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral infections
Young Adult
title Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A11%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20HIV%20on%20Liver%20Fibrosis%20Among%20HCV-Infected%20African%20Americans&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Silver,%20D.&rft.date=2013-05-01&rft.volume=56&rft.issue=9&rft.spage=1280&rft.epage=1283&rft.pages=1280-1283&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1093/cid/cit037&rft_dat=%3Cjstor_pubme%3E23483469%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1324574251&rft_id=info:pmid/23378283&rft_jstor_id=23483469&rfr_iscdi=true